Bobbie Pharmaceutical Services: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Bobbie Pharmaceutical Services
Largest movements
- Financial fixed assets +€12.2m
up €12.2m (+37.7%), from €32.4m to €44.7m
of which Affiliated companies: +€12.2m
- Receivables within one year +€900,688
up €900,688 (+121%), from €743,620 to €1.6m
of which Trade receivables: +€733,716
- Intangible fixed assets +€502,647
up €502,647 (+732%), from €68,653 to €571,300
- Contributions +€8.5m
up €8.5m (+163%), from €5.3m to €13.8m
- Other debts +€3.3m
up €3.3m (+1,655%), from €200,000 to €3.5m
- Debts after one year +€1.6m
up €1.6m (+8.6%), from €18.1m to €19.7m
- Reserves -€805,167
down €805,167 (-17.8%), from €4.5m to €3.7m
- Trade debts +€563,063
up €563,063 (+706%), from €79,772 to €642,835
- Services and other goods +€1.4m
up €1.4m (+883%), from €160,614 to €1.6m
- Financial income -€999,154
down €999,154 (-99.9%), from €1.0m to €846
- Turnover -€425,667
down €425,667 (-21.8%), from €2.0m to €1.5m
- Financial charges +€408,226
up €408,226 (+49.9%), from €818,660 to €1.2m
- Taxes -€227,136
down €227,136 (-100%), from €227,136 to €0
From the 31-12-2024 result to the 31-12-2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 31-12-2024 and 31-12-2025 balance sheets and the 31-12-2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 31-12-2024 | 31-12-2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €33,330,090 | €46,964,534 | +€13.6m | +40.9% |
| Fixed assets | 21/28 | €32,503,215 | €45,236,065 | +€12.7m | +39.2% |
| Intangible fixed assets | 21 | €68,653 | €571,300 | +€502,647 | +732% |
| Tangible fixed assets | 22/27 | - | €9,735 | +€9,735 | |
| Plant, machinery and equipment | 23 | - | €9,735 | +€9,735 | |
| Financial fixed assets | 28 | €32,434,562 | €44,655,030 | +€12.2m | +37.7% |
| Affiliated companies | 280/1 | €32,434,562 | €44,654,460 | +€12.2m | +37.7% |
| Participating interests | 280 | €32,434,562 | €44,654,460 | +€12.2m | +37.7% |
| Other financial fixed assets | 284/8 | - | €570 | +€570 | |
| Amounts receivable and cash guarantees | 285/8 | - | €570 | +€570 | |
| Current assets | 29/58 | €826,875 | €1,728,469 | +€901,594 | +109% |
| Stocks and contracts in progress | 3 | €0 | €0 | = | |
| Amounts receivable within one year | 40/41 | €743,620 | €1,644,308 | +€900,688 | +121% |
| Trade receivables | 40 | €495,420 | €1,229,136 | +€733,716 | +148% |
| Other amounts receivable | 41 | €248,200 | €415,172 | +€166,972 | +67.3% |
| Cash at bank and in hand | 54/58 | €83,255 | €79,683 | -€3,572 | -4.3% |
| Deferred charges and accrued income | 490/1 | - | €4,478 | +€4,478 | |
| Total equity and liabilities | 10/49 | €33,330,090 | €46,964,534 | +€13.6m | +40.9% |
| Equity | 10/15 | €9,766,290 | €17,506,021 | +€7.7m | +79.2% |
| Contributions | 10/11 | €5,250,000 | €13,794,898 | +€8.5m | +163% |
| Reserves | 13 | €4,516,290 | €3,711,123 | -€805,167 | -17.8% |
| Distributable reserves | 133 | €4,516,290 | €3,711,123 | -€805,167 | -17.8% |
| Amounts payable | 17/49 | €23,563,800 | €29,458,513 | +€5.9m | +25.0% |
| Amounts payable after more than one year | 17 | €18,121,429 | €19,687,853 | +€1.6m | +8.6% |
| Financial debts | 170/4 | €18,121,429 | €19,687,853 | +€1.6m | +8.6% |
| Credit institutions | 173 | €9,371,429 | €11,887,853 | +€2.5m | +26.9% |
| Other loans | 174 | €8,750,000 | €7,800,000 | -€950,000 | -10.9% |
| Amounts payable within one year | 42/48 | €5,112,622 | €9,265,923 | +€4.2m | +81.2% |
| Current portion of amounts payable after more than one year | 42 | €874,286 | €1,277,142 | +€402,856 | +46.1% |
| Financial debts | 43 | €3,600,000 | €3,609,127 | +€9,127 | +0.3% |
| Credit institutions | 430/8 | €3,600,000 | €3,609,127 | +€9,127 | +0.3% |
| Trade debts | 44 | €79,772 | €642,835 | +€563,063 | +706% |
| Suppliers | 440/4 | €79,772 | €642,835 | +€563,063 | +706% |
| Taxes, remuneration and social security | 45 | €358,565 | €227,136 | -€131,429 | -36.7% |
| Taxes | 450/3 | €358,565 | €227,136 | -€131,429 | -36.7% |
| Other amounts payable | 47/48 | €200,000 | €3,509,684 | +€3.3m | +1,655% |
| Accrued charges and deferred income | 492/3 | €329,749 | €504,737 | +€174,988 | +53.1% |
| Operating income | 70/76A | €1,954,000 | €1,742,342 | -€211,658 | -10.8% |
| Turnover | 70 | €1,954,000 | €1,528,333 | -€425,667 | -21.8% |
| Own construction capitalised | 72 | - | €214,009 | +€214,009 | |
| Operating charges | 60/66A | €295,563 | €1,668,049 | +€1.4m | +464% |
| Goods for resale, raw materials and consumables | 60 | €111,401 | €0 | -€111,401 | -100% |
| Purchases | 600/8 | €111,401 | €0 | -€111,401 | -100% |
| Services and other goods | 61 | €160,614 | €1,578,681 | +€1.4m | +883% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €22,830 | €88,077 | +€65,247 | +286% |
| Other operating charges | 640/8 | €718 | €1,291 | +€573 | +79.7% |
| Operating profit (loss) | 9901 | €1,658,437 | €74,293 | -€1.6m | -95.5% |
| Financial income | 75/76B | €1,000,000 | €846 | -€999,154 | -99.9% |
| Recurring financial income | 75 | €1,000,000 | €846 | -€999,154 | -99.9% |
| Income from financial fixed assets | 750 | €1,000,000 | €0 | -€1.0m | -100% |
| Income from current assets | 751 | - | €846 | +€846 | |
| Other financial income | 752/9 | €0 | €0 | +€0 | |
| Financial charges | 65/66B | €818,660 | €1,226,885 | +€408,226 | +49.9% |
| Recurring financial charges | 65 | €818,660 | €1,226,885 | +€408,226 | +49.9% |
| Debt charges | 650 | €817,232 | €1,199,934 | +€382,702 | +46.8% |
| Other financial charges | 652/9 | €1,428 | €26,952 | +€25,524 | +1,788% |
| Profit (loss) for the period before taxes | 9903 | €1,839,778 | -€1,151,746 | -€3.0m | |
| Income taxes | 67/77 | €227,136 | €0 | -€227,136 | -100% |
| Taxes | 670/3 | €227,136 | €0 | -€227,136 | -100% |
| Profit (loss) for the period | 9904 | €1,612,642 | -€1,151,746 | -€2.8m | |
| Profit (loss) for the period to be appropriated | 9905 | €1,612,642 | -€1,151,746 | -€2.8m |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.